M&A / successionCH· 2mo ago
Samsung Biologics buys PolyPeptide for $1.8bn
Samsung Biologics announced an all-cash tender offer to acquire PolyPeptide Group AG for about CHF 1.46 billion ($1.8 billion), signaling a bold, large-scale expansion into peptide CDMO capabilities.
Sponsored
Launch your RWA with Curio
Tokenize your real-world asset with Curio
Intent
WATCH· 53intent / 100
Samsung Biologics
companyCH
Daily 5 RWA signals
Five signals in your inbox each morning. Email only.
Free. The daily 5 lands at 07:00 UTC, nothing else. One-click unsubscribe in every email.